CBSET is a translational research institute with over a decade of experience managing GLP-compliant programs in support of regulatory filings. The company was founded in 2006 as a collaborative fusion combining the cutting-edge research and technology focus from the MIT, the clinical relevance and medical expertise of Brigham and Woman Hospital system, and the logistical and operational experience of a large preclinical CRO, all combined with the mission of advancing novel, technologically-challenging therapies into clinical testing.
Legend
Available Timeslot
Scheduled Appointment
Personal Appointments
Appointment Request
Blocked Timeslot
Restricted Timeslot
Copyright © American College of Toxicology. All rights reserved.
You may view the ACT Privacy Policy, Code of Conduct, provide consent to ACT
to email you communications, or unsubscribe to stop receiving further ACT communication.
Privacy Policy | Code of Conduct | Provide Consent | Unsubscribe